The report "RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019" The global transcriptomics market is estimated to be worth $1985.5 million by the end of 2014 and is expected to reach $3,773.0 million by 2019, at a CAGR of 13.7% from 2014 to 2019.
Browse 217 market data tables with 20 figures spread through 300 pages and in-depth TOC on "RNA Analysis/Transcriptomics Market
http://www.marketsandmarkets.com/Market-Reports/trancriptomics-market-240344576.html
Early buyers will receive 10% customization on reports.
In this report, the market is segmented on the basis of different types of technologies, applications, end-users, and geographies. This report also discusses the key market drivers, restraints, opportunities, and challenges. The global market is estimated to be worth $1985.5 million by the end of 2014 and is expected to reach $3,773.0 million by 2019, at a CAGR of 13.7% from 2014 to 2019.
Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=240344576
In 2013, North America region holds the major share in the global transcriptomics market, followed by Europe and Asia-Pacific..The major share of the North American region is primarily attributed to the presence and expansion of major pharmaceutical and biotechnology companies in this region, especially in the U.S..
The prominent players in the market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).
For Customization on this report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=240344576